Veterinary & Biosecurity
WHO in an appraisal Visit to CoVAB
The World Health Organisation Regional Experts Advisory Committee on Traditional Medicine for Covid-19 Response on Monday 7th March 2022 visited the College of Veterinary Medicine, Animal Resources and Bio Security (CoVAB) to take stock of the developments in clinical trials and other efforts in the development of drugs and vaccines to address COVID 19.
The team that made a guided tour of the facilities and activities undertaken in the Centre for Bio Security and Global Health (CeBIGH) was also briefed about a number of ongoing studies.
The Head of the delegation of the WHO/REACT mission Prof. Joseph Okeibunor said the team of regional experts was at the college to take a look at the infrastructure in place, document the successes so far realised in the clinical efforts, identify gaps and to make recommendations for further support towards the ongoing efforts.
He said the visiting team would identify areas of support towards the acceleration of the processes of the development of traditional medicine to address COVID- 19.
Prof. Joseph Okeibunor was happy to note that there were already a number of successful interventions in the use of traditional medicine in the treatment of COVID 19, citing the example of the remedy in Madagascar and that the mission of the world Health organization at COVAB was to take stock of what was happening in regard to the processing of Traditional Medicine in order to ensure standardization and proper packaging to levels that were internationally satisfactory.
He said their mission in the college was to make a rapid appraisal of the available capacities in regard to internationally set standards and also come up with a plan to provide technical support in raising the national capacity in the development of Traditional medicine.
While welcoming the team to the College, Prof. Norbert Frank Mwiine, the Principal CoVAB said Makerere University was celebrating 100 years of its existence and that this period was characterized by lots of research output in the region and globally. He said Uganda and Africa in general was naturally endowed and that in the past parents and grandparents used traditional medicine for various ailments including treatment of cattle. He urged researchers to take on the duty of identifying such knowledge and information the way it was passed on to the present generation.
He said the College had for the past sixteen years been involved in research with a number of successful outcomes as evidenced in Covidex, a product by Professor Ogwang, who was one of the beneficiaries of the programs offered at the College. He said the President of the republic of Uganda gave a go ahead to such products in order to increase the care for the people infected with COVID 19, amidst the limited number of vaccinated people and that the College was proud to be associated with the success realised.
‘In western Uganda where I grew up, I learnt how to treat animals using traditional medicine, he said adding that the ongoing research at the College is embracing ethnobotany and not purely western medicines.
The representative form the Ministry of Science, Technology and Innovation said as a Ministry, they were proud of CoVAB and that researchers at the College were some of the initial Scientists the Ministry worked with in the establishment of central laboratory facilities and drug development. She commended the contribution made by Prof. John David Kabasa as Principal Investigator who was instrumental in the implementation of this Presidential Initiative since the year 2020 that helped in nurturing the pathogen economy. ‘We needed central facilities because many institutions were not in position to set up such initiatives’ she said. She noted that the Scientists were ready for the clinical trials as well as animal trials despite the gaps identified. She said the ministry set up a number of teams of innovators some in the academia while others were out there in the communities.
In order to appreciate the positioning of traditional medicine in the College, a presentation was made about the central Laboratory Animal Research Facility (CLARF). It was explained that the process was on to establish a state of the Art animal house to include both large and small experimental animals at CoVAB for production, testing and diagnosis therapeutics.
The goal was to commercially produce biological molecules for diagnosis, treatment and control of infectious diseases as well as breed and sell lab animal services
Prof. Enoch Matovu further illustrated a number of ongoing research projects in the Centre for Bio Security and Global Health, a centre focused on strategic research. These included the Anti-Tick Vaccine development project, the Safe fish project, COVID 19 Elisa surveillance and the COVID 19 Sub Unit Vaccine among many others.
The WHO team among others comprised of Ossy M.J Kasilo, Regional Advisor for Traditional Medicine from Brazaville Congo, Prof Motlalepulan G. Matsabisa from University of Free State, South Africa.
The Visit by the team from WHO follows a number of earlier processes that started off with the Office of the President’s decision to drive 8 industrial value chains that were prioritised for development one of which was the pathogen economy or pathogen Industrial chains. One of the components of these industrial chains was in the natural products or herbal industry under the stewardship of Prof. John David Kabasa.
CoVAB was identified as a major stakeholder in the natural products Industry in Uganda and Africa. It hosted and coordinated the development of African natural herbal products, research and training network which involved a number of countries in east Africa including Uganda, Kenya, Tanzania and Malawi. To date, The network has trained over 20 PhDs and 38 MSC Scientists.
Veterinary & Biosecurity
Prof. Clovice Kankya Assumes Leadership at the College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB)
Prof. Clovice Kankya officially assumed leadership of Makerere University’s College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB) on Thursday, September 17, 2026, taking over from outgoing principal Prof. Frank Norbert Mwiine in a handover ceremony presided over by Chief Human Resources Officer Deus Mujuni.
Upon assuming office, Prof. Clovice Kankya has laid out a six-pillar vision to transform the College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB). The vision focuses on shifting from lecture-based to competence-driven teaching, advancing impactful research that translates into innovation and national development.
Further, he said his leadership will support building valuable partnerships that strengthen staff capacity and global contribution. He emphasized treating people as the greatest resource by addressing staff attrition and fostering mentorship, while reinforcing governance and accountability to ensure institutional trust. Finally, he pledged to create a listening college with open communication channels between staff and students, positioning CoVAB as a hub of excellence, innovation, and impact.
Prof. Clovice Kankya, in his maiden address as Principal CoVAB, began with heartfelt appreciation: “I stand before you with a profound sense of gratitude, humility, and responsibility.” He pledged to confront challenges honestly, build on existing achievements, and transform ideas into measurable outputs. Emphasizing his leadership philosophy, he declared that it is anchored on “continuity where continuity serves, change where change is necessary, and innovation where innovation can create greater impact.”
A Call to Collective Action
Prof. Kankya urged students to challenge the college intellectually and prepare to become solution creators rather than job seekers. He called on staff for active participation and constructive criticism, and encouraged researchers and partners to form multidisciplinary teams tackling Uganda’s pressing problems.
Further, he pledged to lead with consultation, accountability, and consensus-building. “Today marks the beginning of a new chapter. It’s not a chapter that I write alone; it’s a chapter that we shall write together,” he said. “Together, let us move CoVAB from retention to practice, from knowledge to innovation, and from innovation to impact.”
Prof. Kankya envisions CoVAB as a hub of academic excellence, innovation, and impact — with improved infrastructure, digital transformation, enhanced staff development, and financial sustainability. His leadership is expected to strengthen academic programs, enhance resource mobilization, and steer the college toward greater influence in veterinary medicine and animal resources, both in Uganda and beyond.
Legacy of Prof. Frank Norbert Mwiine at CoVAB
Outgoing Principal Prof. Mwiine highlighted milestones during his tenure, including the construction of a 980-million-shilling hostel at Buyana Stock Farm, roofing of the CoVAB building, acquisition of a bus for student transport, provision of 500 lecture hall seats, and painting of the college building without drawing on university funds. Yet, he also pointed to persistent challenges such as staffing gaps, unimplemented departmental restructuring, and high staff attrition. He urged his successor to remain resilient, stressing that resource mobilization often comes with resistance and criticism.
The Chief Human Resources Officer for Makerere University, Mr. Deus Mujuni commended Prof. Mwiine for leaving an indelible mark on the college and urged Prof. Kankya to build on that legacy. He emphasized continuity, urging the new principal to consult past leaders and rely on institutional memory, while reminding staff to extend the same trust and dedication to the incoming leadership.
The Minister for Science, Technology and Innovation, Rt. Hon. Eng. Asiimwe Jonard, visited the College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB) during his maiden official visit to Makerere University, commending the tremendous research work ongoing at CoVAB and across the University.
In his remarks, the Minister noted that his visit to the University highlighted the pivotal role of research, technology, and innovation in shaping Uganda’s economic transformation and showcased Makerere’s capacity to translate groundbreaking scientific discoveries into practical solutions that address both national and global challenges.
The visit, held on September 16th, 2026, was anchored under the theme “Research Infrastructure, Emerging Technologies and Enterprise Creation.” It offered the Minister an opportunity to tour CoVAB’s state-of-the-art facilities at the Centre for Global Biosecurity and Biomolecular Technology (CeBioTech) and engage directly with faculty, researchers, and students. He commended the college for its tremendous contributions to animal health, food security, and biosecurity, emphasizing that these areas are vital to building a resilient and sustainable economy for Uganda.
While addressing college staff, researchers, and other stakeholders, the Minister emphasized that universities must serve as engines of innovation, moving beyond scholarly work to commercialization. He commended CoVAB’s vaccine development for both humans and animals, describing it as a cornerstone of Uganda’s biosecurity agenda. He further highlighted the importance of integrating social sciences into innovation, noting that project management and product development strategies are essential to fast-track research outputs into viable enterprises.
The Minister toured several flagship facilities at CoVAB, including the Central Laboratory Animal Research Facility, which provides laboratory animal services and pre-clinical trial support; RePROVaD, which designs recombinant proteins and subunit vaccines for emerging infectious diseases such as COVID-19 and Mpox; the Anti-Tick Vaccine project, which addresses the persistent challenge of ticks and tick-borne diseases affecting livestock productivity; and BIOMARKER, which develops antibody-based diagnostics to strengthen disease detection. These initiatives, he noted, demonstrate Makerere University’s capacity to contribute meaningfully to both national and global health challenges.
Looking ahead, the Minister outlined priority actions where CoVAB is expected to play a leading role. These include advancing veterinary innovations toward certification and commercialization, leveraging artificial intelligence to strengthen Uganda’s pathogen economy, positioning veterinary science as a driver of agro‑industrialization, developing sustainable models for shared diagnostic and biosecurity laboratories, and providing commercialization support for innovators in areas such as intellectual property, regulation, standards, and market access. By focusing on these areas, he emphasized, CoVAB will not only enhance Uganda’s scientific capacity but also accelerate the country’s journey toward economic resilience and prosperity.
Asiimwe pledged continued support for Makerere University and encouraged the development of structured University–Industry exchange models to ensure veterinary research translates into enterprise creation. He also emphasized the importance of self-sustainability for research centers, noting that revenue generation is key to long-term impact.
The Vice Chancellor, Prof. Barnabas Nawangwe, thanked the Minister for recognizing CoVAB’s strategic role and reaffirmed Makerere’s commitment to advancing veterinary science and innovation for Uganda’s prosperity.
Veterinary & Biosecurity
Parliamentary Committee on Science, Technology and Innovation Reviews Uganda’s Emerging Science Ventures
By Jacinta Nakaye
Uganda’s drive to strengthen science, technology and innovation took center stage as the Parliamentary Committee on Science, Technology and Innovation toured Makerere University’s Centre for Biosecurity and Biomolecular Technology (CeBIOTECH). The centre is hosted at the College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB). The visit aimed to assess the progress of ventures supported under the Science, Technology and Innovation–Office of the President (STI-OP).
The visit brought legislators, scientists, and innovators together around a shared question: How can Uganda turn investments in scientific research into practical technologies, enterprises, and solutions that respond to national development challenges?
At CeBIOTECH, the Committee was taken through a portfolio of emerging science ventures, including Central Laboratory Animal Research Facility, which focuses on providing lab animal services, pre-clinical trial support, and specialized training to accelerate biosecurity and health solutions; RePROVaD, which focuses on designing and manufacturing recombinant proteins and subunit vaccines for emerging infectious diseases such as COVID-19 and Mpox; the Anti-Tick Vaccine venture focused on addressing the challenge of ticks and tick-borne diseases; and BIOMARKER focused on developing Antibody-based diagnostics.
The delegation also toured laboratories within the Centre where research, product development and other activities supporting the ventures are undertaken.
The engagement offered the Committee a first-hand view of the scientific infrastructure, expertise and processes underpinning Uganda’s efforts to move research beyond academic discovery and towards innovation, enterprise development and eventual application.
Where science meets national priorities
For years, Uganda has invested in research and generated scientific knowledge across universities and research institutions. However, converting that knowledge into products and services that reach communities and markets remains one of the country’s most important innovation challenges. The ventures showcased at CeBIOTECH represent an attempt to bridge this gap.
Although they operate in different areas, the ventures share a common pathway using scientific research and technological expertise to develop solutions with potential to address challenges facing Ugandans while contributing to economic growth.
The Parliamentary Science Committee’s visit consequently provided more than an opportunity to observe ongoing research. It created a platform for legislators to interact with the scientists behind the innovations and gain insight into the journey from research concept to a potentially viable product or enterprise.
That journey can involve years of research, laboratory experimentation, testing, validation, regulatory requirements, intellectual property protection, investment, and commercialisation.
A diverse portfolio of innovation
The diversity of ventures at CeBIOTECH reflects the broad scope of Uganda’s science and innovation agenda.
The CLARF, REPROVaD, and BIOMARKER ventures demonstrate the range of scientific work being pursued. At the same time, the Anti-Tick Vaccine Venture highlights efforts to address one of the persistent challenges affecting livestock production.
Rather than viewing the ventures as isolated projects, the visit highlighted the importance of building an ecosystem in which scientific discoveries can be nurtured into sustainable enterprises.
Such an ecosystem requires more than laboratory facilities. It depends on skilled human resources, research financing, modern infrastructure, regulatory support, partnerships, intellectual property management, manufacturing capacity, and market access.
Taking the fight against ticks beyond conventional control
One of the ventures presented to the Committee was the Tick Control Innovations Initiative Ltd.’s Anti-Tick Vaccine Venture, which is developing a vaccine aimed at controlling ticks and reducing the burden of tick-borne diseases in cattle.
Ticks and tick-borne diseases continue to present significant challenges to livestock production, affecting animal health and productivity and placing additional costs on farmers.
The development of an anti-tick vaccine represents an innovative approach to complement conventional tick-control measures and potentially provide farmers with an additional tool for managing the problem.
The inclusion of the venture among the STI-OP innovations showcased to Parliament demonstrates how scientific research can be directed towards challenges with direct implications for agriculture, livestock production and rural livelihoods.
For Uganda, the significance of such innovations lies not only in the scientific breakthrough itself, but also in the possibility of developing locally generated technologies that can eventually reach farmers and contribute to a more productive livestock sector.
The laboratories behind the innovations
A significant part of the Committee’s programme was the tour of CeBIOTECH’s laboratories. The tour offered members an opportunity to see the facilities where scientific investigations and activities supporting the various ventures are undertaken.
Behind every innovation that eventually reaches the market is a substantial amount of work that is rarely visible to the public: laboratory experiments, sample analysis, quality control, testing, documentation, and validation.
The laboratory visits therefore helped demonstrate that successful innovation requires sustained investment in scientific infrastructure and the people who operate it. For Uganda’s science ventures to mature into viable enterprises, maintaining and strengthening such infrastructure will remain critical.
Parliament and the science agenda
The engagement also highlighted the important role Parliament can play in creating an environment in which scientific innovations can thrive.
While researchers generate knowledge and innovators develop technologies, policy and public investment can determine whether promising innovations receive the support needed to progress.
The Parliamentary Science Committee’s interaction with the ventures therefore provided an opportunity to understand the realities of research and innovation. Such an engagement strengthened the connection between policymakers and scientists, ensuring that decisions concerning science, technology and innovation are informed by the practical experiences of those working within the sector.
A step towards an innovation-driven Uganda
The Parliamentary Committee on Science, Technology, and Innovation’s visit to CeBIOTECH comes at a time when Uganda continues to position science, technology, and innovation as central to national transformation. The ventures visited provide a glimpse into what this ambition can look like in practice; scientists working on locally relevant challenges, laboratories supporting research and development, and emerging enterprises seeking to convert scientific knowledge into usable solutions.
The visit also underscored the importance of sustained collaboration among government, Parliament, universities, research institutions, private-sector players and investors. For the innovators at CeBIOTECH, the engagement provided an opportunity to demonstrate progress, highlight the potential of their work and draw attention to the support required to move their innovations to the next level. For Parliament, it offered a closer look at the people, facilities, and scientific processes behind Uganda’s emerging innovation landscape.
Ultimately, the story unfolding at CeBIOTECH is not simply about laboratories or individual ventures. It is about Uganda’s capacity to generate its own solutions, build enterprises around scientific knowledge, and turn research investment into tangible national value.
As the country pursues a more knowledge-driven economy, the progress of ventures such as CLARF, SUBUNIT, the Anti-Vaccine Venture, RePROVaD, and BIOMARKER will be an important measure of how effectively Uganda can move from research to innovation, from innovation to enterprise, and from enterprise to impact.
-
General1 week agoAR Department Bids Farewell to Mr. Ssentongo and Ms. Akoli
-
General2 weeks agoProf. Sarah Ssali urges the Makerere University Community to embrace local philanthropy
-
General2 weeks ago“We are moving in the right direction” Prof Nawangwe to Press
-
General5 days agoCall for Applications: RLRH Graduate Traineeship Programme
-
Agriculture & Environment2 weeks agoMakerere Hosts Inaugural Falling Walls Lab Competition as Innovators Pitch Solutions to National Challenges